We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Gold Nanoparticles Designed to Track Viruses

By LabMedica International staff writers
Posted on 30 Jan 2014
Finish scientists have developed a unique strategy for the study of Enterovirus structures and their biologic processes. More...
The new approach will help in obtaining new data on viruses functioning in cells and tissues as well as on the mechanisms of virus opening inside cells. This new information will be important, for instance, for developing new antiviral drugs and vaccines.

The study’s findings were published January 13, 2014, in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS). The research, conducted by researchers at the Nanoscience Center (NSC) of the University of Jyväskylä (Finland), was funded by the Academy of Finland (Helsinki) and Tekes’ (Länsi-Pasila, Finland) FiDiPro project NOVAC (Novel Methods for Vaccination and Virus Detection).

The infection mechanisms and infectious pathways of enteroviruses are still rather poorly known. Earlier research from the group of NSC’s Dr. Varpu Marjomäki have centered on the cellular factors that are important for the infection caused by selected enteroviruses. The understanding of virus processes of opening and releasing the viral genome in cellular structures for starting new virus production is still mostly unknown. Moreover, the knowledge of infectious processes in tissues is restricted by the lack of effective tools for detecting virus infections.

The newly developed technique involves a chemical modification of a known thiol-stabilized gold nanoparticle, the so-called Au102 cluster, which was first synthesized and structurally deciphered by Dr. Roger D. Kornberg’s team, from Stanford University (Stanford, CA, USA), in 2007 and later characterized at the NSC by the groups of Prof. Hannu Häkkinen and Prof. Mika Pettersson in collaboration with Dr. Kornberg.

The organic thiol surface of the Au102 particles is modified by attaching linker molecules that make a chemical bond to sulfur-containing cysteine residues that are part of the surface structure of the virus. Several tens of gold particles can bind to a single virus, and the binding pattern looks like dark tags reflecting the overall shape and structure of the virus. The gold particles allow for studies on the structural changes of the viruses during their lifespan.

In addition, the study’s findings revealed that the viruses’ infection approach is not compromised by the attached gold particles, which indicates that the labelling strategy does not interfere with the normal biologic functions of viruses inside cells. This aids new research on the virus structures from samples gathered from inside cells during the various phases of the virus infection, and makes it possible to obtain new information on the mechanisms of virus uncoating.

The new technique, according to the researchers, also allows for tracking studies of virus pathways in tissues. This is significant for the further determination of acute and chronic symptoms caused by viruses. Finally, the method is expected to be useful for developing new antiviral vaccines based on virus-like particles.

The method was developed at the NSC as a wide, cross-disciplinary collaboration between physicists, chemists, and biologists.

Related Links:

University of Jyväskylä



New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.